スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Bortezomib)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
C2C12(RCB0987)
71900
Increased 20S Proteasome Expression and the Effect of Bortezomib during Cisplatin-Induced Muscle Atrophy.
Biol Pharm Bull
2022-1-1
Pubmed
Full text
ヒト・動物細胞
MKN7(RCB0999)
,
MKN45(RCB1001)
,
MKN1(RCB1003)
61288
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
Int J Oncol
2011-12-1
Pubmed
Full text
ヒト・動物細胞
ST2(RCB0224)
,
MC3T3-E1(RCB1126)
44456
Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
Int J Hematol
2013-7-1
Pubmed
Full text
ヒト・動物細胞
Rat-1(RCB1830)
44446
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Oncogene
2014-4-24
Pubmed
Full text
ヒト・動物細胞
PCM6(RCB1460)
44331
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells.
PLoS One
2013-1-1
Pubmed
Full text
ヒト・動物細胞
HuH-7(RCB1366)
43344
Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation.
Hepatology
2008-6-1
Pubmed
Full text
ヒト・動物細胞
42663
Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast.
Biol Pharm Bull
2006-6-1
Pubmed
Full text
ヒト・動物細胞
KU812(RCB0495)
,
K562
37627
Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Cancer Res
2009-5-1
Pubmed
Full text
遺伝子材料
CSII-CMV-MCS-IRES2-Venus (RDB04383)
35724
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.
J Biol Chem
2013-8-30
Pubmed
Full text
遺伝子材料
CSII-CMV-MCS-IRES2-Venus (RDB04383)
12721
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
Blood
2010-7-22
Pubmed
Full text